These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 428129

  • 1. [Treatment of hypercalcemia with Asu 1,7 eel calcitonin].
    Kudo S, Nakamura I, Sakagami M, Fukuchi S.
    Horumon To Rinsho; 1979 Feb; 27(2):179-83. PubMed ID: 428129
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic effect of synthetic eel calcitonin on patients with hypercalcemia (author's transl)].
    Tomita A, Nakagawa H, Takita S, Uchikawa K, Wanibe H.
    Horumon To Rinsho; 1979 Aug; 27(8):897-902. PubMed ID: 487625
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
    Adachi I, Kimura S, Yamaguchi K, Suzuki M, Abe K.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
    [Abstract] [Full Text] [Related]

  • 6. Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man.
    Nilsson O, Almqvist S, Karlberg BE.
    Acta Med Scand; 1978 Aug; 204(4):249-52. PubMed ID: 358762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.
    Brautbar N, Luboshitzky R.
    Arch Intern Med; 1977 Jul; 137(7):914-6. PubMed ID: 879932
    [Abstract] [Full Text] [Related]

  • 9. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M, Takami H.
    Oncol Rep; 1998 Jul; 5(1):197-9. PubMed ID: 9458321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of calcitonin treatment in hypercalcemia associated with malignant neoplasms].
    Miura S, Yoshida Y, Murai H.
    Horumon To Rinsho; 1975 Aug; 23(8):809-15. PubMed ID: 1238199
    [No Abstract] [Full Text] [Related]

  • 12. Human synthetic calcitonin therapy for hypercalcemia of immobilization.
    Kaul S, Sockalosky JJ.
    J Pediatr; 1995 May; 126(5 Pt 1):825-7. PubMed ID: 7752017
    [Abstract] [Full Text] [Related]

  • 13. [Calcitonin therapy of the hypercalcemia syndrome].
    Várvölgyi C, Mátyus J, Lörincz I.
    Orv Hetil; 1988 Jun 19; 129(25):1343-4. PubMed ID: 3194130
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Calcitonin. Research and clinical aspects].
    Haas HG, Dambacher MA, Olah AJ.
    Internist (Berl); 1971 May 19; 12(5):205-10. PubMed ID: 4931503
    [No Abstract] [Full Text] [Related]

  • 18. Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
    Caro JF, Besarab A, Glennon JA.
    Cancer Treat Rep; 1978 Oct 19; 62(10):1561-3. PubMed ID: 152145
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical application of calcium regulating hormone (author's transl)].
    Orimo H.
    Horumon To Rinsho; 1980 Oct 19; 28(3):269-74. PubMed ID: 7398100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.